Variable | Group A | Group B | Group C | Group B + C |
---|---|---|---|---|
Total population (%) | 145 (73.98) | 25 (12.76) | 26 (13.27) | 51 (26.02) |
Male gender (%) | 95 (66) | 16 (12.8) | 14 (10.94) | 30 (24) |
Female gender (%) | 50 (70.42) | 9 (12.68) | 12 (16.9) | 21 (29.58) |
Age | 72.43 ± 8.97 | 72.36 ± 8.48 | 71.00 ± 8.99 | 71.65 ± 9.76 |
Course of disease | 17.09 ± 13.51 | 15.04 ± 12.04 | 17.88 ± 12.82 | 16.55 ± 1.95 |
Hospital stays | 13.58 ± 7.88 | 12.80 ± 8.43 | 19.37 ± 11.25 *# | 16.71 ± 13.49 |
Death (%) | 9 (6) | 4 (16) | 3 (12) | 7 (13.73) |
Comorbidities | Â | Â | Â | Â |
 Hypertension (%) | 39 (27) | 7 (28) | 15 (58) | 22 (43.13) |
 CHD (%) | 31 (21) | 7 (28) | 13 (50) | 20 (39.22) |
Laboratory values (at admission) | Â | Â | Â | Â |
 Troponin (ng/ml) | 0.09 ± 0.29 | 0.11 ± 0.39 | 0.37 ± 0.06 *# | 0.25 ± 0.45 |
 D-Dimer (µg/mL) | 1.94 ± 2.11 | 1.61 ± 1.13 | 1.52 ± 0.86 | 1.56 ± 1.49 |
 PaO2 (mmHg) | 60.98 ± 15.05 | 51.66 ± 13.54** | 57.11 ± 14.83 | 55.98 ± 14.19* |
 Hb (g/l) | 130.28 ± 20.41 | 131.04 ± 13.57 | 128.42 ± 27.78 | 130.02 ± 29.51 |
 BNP (pg/ml) | 318.39 ± 625.66 | 414.16 ± 705.81 | 384.38 ± 761.74 | 399.47 ± 799.45 |